A radio-pathological fusion model for predicting PD-L1 expression and immunotherapy response in non-small cell lung cancer
Dingpin Huang, Fangyi Xu, Yi Gan, Liya Ding, Kaihua Lou, Yongcen Li, Dong Xie, Haiping Zhang, Lei Shi, Rui Xu, Hongjie Hu · 2026
Read A radio-pathological fusion model for predicting PD-L1 expression and immunotherapy response in non-small cell lung cancer by Dingpin Huang, Fangyi Xu, Yi Gan, Liya Ding, Kaihua Lou, Yongcen Li, Dong Xie, Haiping Zhang, Lei Shi, Rui Xu, Hongjie Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13269606.txt.
Description
Dingpin Huang and co-authors published a journal article in 2026 building a model that predicts a key immune marker, PD-L1, in non-small cell lung cancer. The model fuses CT scan features with features from stained tissue slides. High marker levels help doctors choose immune therapy for this common lung cancer.
Records from 328 patients were split into training, checking, and test sets, and 55.5 percent of patients were marker positive. The fused model beat either single-source model, with accuracy scores of 0.90, 0.80, and 0.73 across the sets. In a separate group on immune therapy, patients with high model scores lived longer without disease growth. The score stayed predictive when combined with clinical factors.
Catalog record
| CREATOR | Dingpin Huang, Fangyi Xu, Yi Gan, Liya Ding, Kaihua Lou, Yongcen Li, Dong Xie, Haiping Zhang, Lei Shi, Rui Xu, Hongjie Hu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39682 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |